CLICK HERE TO REGISTER FOR FREE!*

This webinar will review the current industry prospective, new FDA enforcement policies for holding corporate officials responsible, current regulations, and the latest technology for managing these risks. Please join ExL Pharma and partners by participating in a 15 minute Interactive Live Q&A after the presentation.

Key Topics

	New FDA Policy to Hold Corporate Officials Responsible
	Best Practices for Ensuring Compliant Messaging
	Technology for managing compliance workflow and compliant content

Webinar Leaders

	David Kriesel David received a degree in pharmacy from the University of Arizona in 1995. David’s first job as the national director of a medical liaison team was with Prometheus Laboratories in San Diego, CA. From Prometheus Laboratories, David moved over to Santarus, Inc. (San Diego) where he is currently employed. Within Santarus, David is responsible for managing the MSL team, various functions within medical affairs, and project manager for a drug in phase III development.
	Christopher R. Hall Mr. Hall places particular emphasis on the heath care, financial service, and defense industries. His subject matter expertise within these industries includes health care fraud and abuse, wire/mail fraud, securities fraud, tax crimes, false claims, government contract fraud, export law violations, and public corruption. He has tried more than 30 cases to verdict in federal courts.
	Jim Zuffoletti Mr. Zuffoletti has been a founder of start up organizations as both an entrepreneur and an intrapreneur. As President of openQ he has been a catalyst for determining the company’s strategic direction and for forging critical relationships with customers in the pharmaceutical, biotech, and medical device industry segments.